2025/2026 Venous Leg Ulcer (VLU) Evidence-Based Care Guide
Compression Is Central to VLU Care. Why Do Recurrence, Delays and Workflow Friction Still Persist?
Summary
Venous leg ulcer care depends on vascular assessment, appropriate compression, wound-bed management and long-term recurrence prevention. Facilities lose continuity when ABPI/Doppler decisions, compression tolerance, wound observations and handovers are recorded in separate places. This guide connects standard VLU care, tissue-environment evidence, balanced wIRA research and one practical institutional workflow.
1. What Is a Venous Leg Ulcer?
Evidence boundary: Published wIRA study observations are provided as technology-background context. They are not CYP8 brand-specific clinical evidence, treatment instructions, or a guarantee of wound healing, pain reduction, functional recovery, or any individual clinical outcome.
A venous leg ulcer is a chronic lower-leg wound associated with venous disease, impaired venous return and sustained venous hypertension. It commonly occurs in the gaiter region and should not be managed as an isolated surface wound.[1][2]
Professional assessment must consider wound history, recurrence, oedema, skin changes, pain, mobility, infection concerns and arterial risk. Vascular assessment, including documented ABPI/Doppler findings where appropriate, is essential before compression decisions are made.[1][2]
For a facility, the first question is therefore not “Which dressing should we use?” It is: Has the vascular boundary been established clearly enough for the team to execute and review the compression plan?
2. Risk Assessment Must Lead to an Action
VLU records become useful when every finding leads to a clear next step.
| Decision area | What the team must establish | Required workflow action |
|---|---|---|
| Arterial risk | Vascular history, pulses, Doppler/ABPI result and warning signs | Confirm the approved compression route or refer for vascular review |
| Venous presentation | Oedema, skin change, ulcer history and recurrence | Record the working care pathway and review date |
| Wound status | Site, size, exudate, wound bed, periwound skin and pain | Define wound-bed and dressing responsibilities |
| Compression tolerance | Comfort, slippage, heat, donning difficulty and removal | Record the reason for interruption and the approved response |
| Recurrence risk | Previous ulcers, mobility, long-term compression and follow-up | Create a post-closure monitoring plan |
ABPI is not a substitute for professional interpretation, and this article does not create universal compression thresholds. The result must be interpreted within the applicable guideline, clinical context and local professional pathway.[1][2]
3. Why VLU Becomes a Long-Term Facility Burden
The burden develops through repeated observation, compression application, skin protection, pain review and handover. Long care cycles, unstable compression tolerance, fragmented records and weak post-closure follow-up can force each shift to restart the same assessment and explanation.
4. The Causal Chain Behind Repeated VLU Care
The visible ulcer is the end of a longer process:
Impaired venous return -> venous hypertension -> capillary pressure and oedema -> inflammatory and microcirculatory disturbance -> reduced local tissue efficiency -> ulcer persistence, pain and exudate -> reduced mobility and lower compression adherence -> further venous dysfunction and recurrence.[2][3]
This chain explains why VLU management cannot stop at the wound surface. It also explains why compression remains central: compression addresses venous hypertension and oedema, which are upstream drivers of the problem.[1][2][3]
5. Standard VLU Care: The Non-Negotiable Foundation
Compression therapy is a core component of VLU management after appropriate vascular assessment.[1][2][3] It works within a wider professional pathway:
| Standard-care element | Primary role |
|---|---|
| ABPI/Doppler and vascular assessment | Establish arterial risk and the professional compression boundary |
| Compression | Support venous return and reduce venous hypertension and oedema |
| Wound-bed and dressing management | Manage exudate, protect the wound and support an appropriate wound environment |
| Debridement and infection review | Address devitalised tissue and identify escalation needs |
| Periwound skin protection | Reduce maceration and further skin damage |
| Mobility and elevation | Support calf-muscle function and venous return where appropriate |
| Post-closure follow-up | Maintain compression, skin checks, education and recurrence prevention |
No photothermal technology replaces these responsibilities. Any supplementary technology must be evaluated around the established vascular, compression, wound-care and referral pathway.
6. Where Standard Care Breaks Down in Daily Execution
The standard pathway is clear, but execution still breaks when ABPI/Doppler findings do not travel with the compression decision, interruptions are recorded without their cause, dressing changes displace vascular and mobility review, or closure ends the record before recurrence prevention is secured.
The practical gap is a shared record connecting assessment, compression, tolerance, wound observations, escalation and recurrence prevention.
7. Why the Local Tissue Environment Still Matters
Even with standard care in place, pain, thermal discomfort, oedema, variable tolerance and slow progression can persist. These observations do not replace vascular assessment; they raise a separate question about supplementary tissue-environment support.
wIRA, or water-filtered infrared-A, uses water filtering to shape the infrared-A spectrum and reduce parts of the radiation associated with unnecessary surface thermal load. Its proposed photothermal effects have been studied through independently measured variables such as tissue temperature, oxygen tension, perfusion, pain and wound-related outcomes.[6]
wIRA equipment does not itself generate ABPI, TcPO₂, perfusion or thermographic measurements. Those measurements remain within authorised professional assessment and research methods.
8. What Does the VLU Evidence Show for wIRA?
Water-filtered infrared-A has been studied as an adjunct to established venous-ulcer care, not as a replacement for vascular assessment, compression, wound-bed management or referral.
Schumann et al., 2011
This randomized, controlled and blinded study enrolled 51 people with chronic venous stasis ulcers. Twenty-five received wIRA plus visible light and 26 received visible light alone alongside standard care.[4]
The prespecified primary measure, the integral of relative ulcer area over time, did not reach statistical significance. At week 9, secondary findings included a clinician-rated wound-healing VAS of 85 versus 67.5 and a healing-trend proportion of 84% versus 50%. Granulation findings also favoured the wIRA group, while wound-area reduction trends did not reach statistical significance.[4]
Mercer et al., 2008
A separate prospective study followed 10 people with 11 recalcitrant chronic venous stasis ulcers. Seven participants reached complete or near-complete closure, and two others had a marked reduction in ulcer size. Pain, analgesic use and thermographic patterns also changed during follow-up.[5]
This was a small, mainly single-cohort study. Only one participant provided a within-person comparison.[5] It cannot be treated as a large randomized trial or proof of universal outcomes.
Evidence boundary
These studies provide indication-matched clinical signals and important limitations. They do not establish CYP8 brand outcomes, prove universal clinical outcomes, or replace compression therapy and the professional vascular pathway.
Early Basel data reported differently across later reviews are not reproduced here because the available secondary sources disagree on the closure-time figure and the complete original report has not been independently verified.
9. How CYP8 Can Be Evaluated in an Institutional Workflow
CYP8 may be evaluated as an equipment-delivery layer for a wIRA photothermal support pathway. It is not an ABPI device, vascular assessment tool, wound measurement system or replacement for standard VLU care.
| Workflow stage | Institutional action | Minimum record |
|---|---|---|
| Professional confirmation | Confirm vascular, compression, wound-care and referral boundaries | Source of confirmation, restrictions and escalation route |
| Baseline | Record the approved care stage and visible or subjective feedback | Site, position, comfort, skin/wound boundary and current compression plan |
| Equipment use | Follow product instructions and institutional SOP | Operator, setting, time, position/distance, tolerance and stop events |
| Handover | Compare records and return abnormalities to the professional pathway | Decision, next responsible person and review date |
| Periodic review | Examine consistency, interruptions and unresolved issues | Record completeness, repeated feedback and action taken |
Institutions should evaluate whether this process improves documentation consistency, staff execution and workflow fit. These are evaluation questions, not pre-proven operational outcomes.
10. Download the VLU Care Pathway Map
The VLU Care Pathway Map brings vascular assessment, compression, wound care, recurrence prevention and technology-evaluation boundaries into one institutional overview.
Use it for team discussion, new-staff orientation, pathway review and handover preparation. Review the resource details, intended use and access path before requesting the resource.
Related reading: ABPI Screening Before VLU Compression Therapy | wIRA Technology | CYP8 Product Evaluation
Common Questions About Venous Leg Ulcer
These questions help institutional teams connect VLU assessment, compression decisions, documentation and evidence review.
ABPI status, arterial-risk notes, ulcer location, exudate, skin condition, pain or local feedback, and escalation limits should be visible in the record.
Teams may record wound appearance without linking edema, compression context, dressing change, skin feedback, and the next review owner.
wIRA evidence can be discussed as technology-background or adjacent clinical evidence only when the claim boundary is stated clearly.
Only as a recordable equipment-support step inside an existing professional pathway, not as a replacement for vascular assessment or compression decisions.
Related Guides
Resources
For: nursing teams and wound-care coordinators.
Purpose: structured screening, handover and review documentation.
Use the Download Center to request available worksheets, checklists and review templates for institutional evaluation.
Resources are intended for institutional review, workflow discussion and professional education. They are not diagnostic tools, clinical instructions or guarantees of clinical outcomes.
VLU Compression Therapy Documentation and Nursing Care-Plan Context
For professional care teams, a venous leg ulcer care pathway is not only a wound-status discussion. A practical VLU compression therapy documentation workflow should also record compression context, dressing changes, skin condition, mobility notes, staff handover, and venous ulcer care plan nursing observations.
This chronic venous leg ulcer care guide is organized for institutional documentation review. It does not replace clinical judgment, vascular assessment, or compression decisions made by qualified professionals.
References
- 1. National Institute for Health and Care Excellence. Clinical Knowledge Summary: Leg ulcer – venous. Official source.
- 2. European Wound Management Association and Wounds Australia. Management of Patients with Venous Leg Ulcers: Challenges and Current Best Practice. 2016. Official PDF.
- 3. Harding K, et al. Simplifying venous leg ulcer management: consensus recommendations. Wounds International. 2015. Official source.
- 4. Schumann H, Calow T, Weckesser S, Müller ML, Hoffmann G. Water-filtered infrared A for the treatment of chronic venous stasis ulcers of the lower legs at home: a randomized controlled blinded study. British Journal of Dermatology. 2011;165(3):541-551. PMID: 21574975. DOI: 10.1111/j.1365-2133.2011.10410.x. PubMed.
- 5. Mercer JB, Nielsen SP, Hoffmann G. Improvement of wound healing by water-filtered infrared-A in patients with chronic venous stasis ulcers of the lower legs including evaluation using infrared thermography. GMS German Medical Science. 2008;6:Doc11. PMID: 19675738. PMCID: PMC2703263. PubMed.
- 6. Hoffmann G. Principles and working mechanisms of water-filtered infrared-A in relation to wound healing. GMS Krankenhaushygiene Interdisziplinär. 2007;2(2):Doc54. PMID: 20204085. PMCID: PMC2831244. PubMed.